Do-Youn Oh

Title: The Innovative Contributions of Do-Youn Oh

Introduction

Do-Youn Oh is a prominent inventor based in Seoul, South Korea. He has made significant strides in the field of cancer therapy through his innovative research and patented methods. His work focuses on improving treatment options for patients suffering from cancer, particularly those with tumors that express the Her2 protein.

Latest Patents

Do-Youn Oh holds a patent for a method titled "Quantifying Her2 protein for optimal cancer therapy." This patent presents improved methods of treatment for cancer patients. The methods identify whether a tumor will respond to treatment with therapeutic agents that target the Her2 protein. By quantifying a specific Her2 fragment peptide using SRM-mass spectrometry in tumor cells collected from patients, the method allows for a comparison to a reference level. This comparison helps determine if a patient will positively respond to treatment with anti-Her2 agents.

Career Highlights

Throughout his career, Do-Youn Oh has worked with notable organizations, including Expression Pathology Incorporated and Seoul National University. His contributions to cancer research have been recognized within the scientific community, and his innovative approaches continue to influence the field.

Collaborations

Do-Youn Oh has collaborated with esteemed colleagues such as Yung-Jue Bang and Todd Hembrough. These partnerships have furthered his research and enhanced the impact of his work in cancer therapy.

Conclusion

Do-Youn Oh's innovative contributions to cancer treatment through his patented methods exemplify the importance of research in improving patient outcomes. His work continues to pave the way for advancements in cancer therapy.